Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 14, Issue 5, 2003, Pages 305-312

  Bujold, E ^a   Chaiworapongsa, T ^b   Romero, R ^a,b   Gervasi, M T ^b   Espinoza, J ^b   Goncalves, L F ^b   Berman, S ^a   Yoon, B H ^c   Kim, Y M ^b  

^a HUTZEL HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Seoul National University   (South Korea)

Author keywords

Acidosis; CD3 CD56+16+; Labor; NK cells; Pre eclampsia; Pregnancy; Umbilical cord blood

Indexed keywords

ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BIRTH; BLOOD ANALYSIS; BLOOD PH; CHORIOAMNIONITIS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOASSAY; IMMUNOPHENOTYPING; LABOR; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METHODOLOGY; MULTIPLE REGRESSION; NATURAL KILLER CELL; NEWBORN; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

EID: 0345538685     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.14.5.305.312     Document Type: Article

References (74)

1. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240-9
2. Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002;9:147-60
3. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-72
4. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506
6. Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001;185:792-7
7. Davidge ST, Signorella AP, Lykins DL, et al. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol 1996;175:1301-6
8. Steinborn A, Sohn C, Sayehli C, et al. Preeclampsia, a pregnancy-specific disease, is associated with fetal monocyte activation. Clin Immunol 2001;100:305-13
9. Mellembakken JR, Aukrust P, Hestdal K, et al. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 2001;38:394-8
10. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, et al. Pre-eclampsia affects the immunophenotype of neonates. Immunol Lett 2001;77:67-71
11. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, et al. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 1984;160:1147-69
12. Janeway CA, Jr. How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci USA 2001;98:7461-8
13. Trinchieri G. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol 1995;7:83-8
14. Hidaka Y, Amino N, Iwatani Y, et al. Changes in natural killer cell activity in normal pregnant and postpartum women: increases in the first trimester and postpartum period and decrease in late pregnancy. J Reprod Immunol 1991;20:73-83
15. Salmeron OJ, Vaquer S, Salmeron I, et al. Pregnancy is associated with a reduction in the pattern of the cytotoxic activity displayed by lymphokine-activated killer cells. Am J Reprod Immunol 1991;26:150-5
16. Russell AS, Miller CL. Sequential studies of NK cell activity in human pregnancy. J Clin Lab Immunol 1986;19:5-9
17. Lee H, Gregory CD, Rees GB, et al. Cytotoxic activity and phenotypic analysis of natural killer cells in early normal human pregnancy. J Reprod Immunol 1987;12:35-47
18. Hill JA, Hsia S, Doran DM, et al. Natural killer cell activity and antibody dependent cell-mediated cytotoxicity in preeclampsia. J Reprod Immunol 1986;9:205-12
19. Kwak JY, Beaman KD, Gilman-Sachs A, et al. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-9
20. Matthiesen L, Berg G, Ernerudh J, et al. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in preeclampsia. Am J Reprod Immunol 1999;41:192-203
21. Chaiworapongsa T, Gervasi MT, Kim JC, et al. Natural killer cell lymphocytes in pre-eclampsia and pyelonephritis. Soc Gynecol Invest 2002;9:182A
22. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997;177:1003-10
23. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25
24. Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996;26:16-21
25. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22: 633-40
26. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nature Rev Immunol 2002;2:957-64
27. Long EO, Rajagopalan S. Stress signals activate natural killer cells. J Exp Med 2002;196:1399-402
28. Moretta L, Bottino C, Pende D, et al. Human natural killer cells: their origin, receptors and function. Eur J Immunol 2002;32:1205-11
29. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9
30. Michaelsson J, Teixeira dM, Achour A, et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002;196:1403-14
31. Thilaganathan B, Abbas A, Nicolaides KH. Fetal blood natural killer cells in human pregnancy. Fetal Diagn Ther 1993;8:149-53
32. Gaddy J, Risdon G, Broxmeyer HE. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 1995;15:527-36
33. Kibler R, Hicks MJ, Wright AL, et al. A comparative analysis of cord blood and adult lymphocytes: interleukin-2 and interferon production, natural killer cell activity, and lymphocyte populations. Diagn Immunol 1986;4:201-8
34. Uksila J, Lassila O, Hirvonen T. Natural killer cell function of human neonatal lymphocytes. Clin Exp Immunol 1982;48: 649-54
35. Baker DA, Milch PO, Salvatore W, et al. Enhancement of maternal and neonatal natural killer cell activity with interleukin-2. Am J Obstet Gynecol 1987;157:780-1
36. Musha N, Yoshida Y, Sugahara S, et al. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Clin Exp Immunol 1998;113:220-8
37. Nomura A, Takada H, Jin CH, et al. Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response. Exp Hematol 2001;29:1169-76
38. Samelson R, Larkey DM, Amankwah KS, et al. Effect of labor on lymphocyte subsets in full-term neonates. Am J Reprod Immunol 1992;28:71-3
39. Thilaganathan B, Meher-Homji N, Nicolaides KH. Labor: an immunologically beneficial process for the neonate. Am J Obstet Gynecol 1994;171:1271-2
40. Kavelaars A, van der PG, Bakker JM, et al. Altered immune function in human newborns after prenatal administration of betamethasone: enhanced natural killer cell activity and decreased T cell proliferation in cord blood. Pediatr Res 1999;45:306-12
41. Ryhanen P, Jouppila R, Lanning M, et al. Natural killer cell activity after elective cesarean section under general and epidural anesthesia in healthy parturients and their newborns. Gynecol Obstet Invest 1985;19:139-42
42. Herson VC, Block C, Eisenfeld LI, et al. Effect of labor and delivery on neonatal polymorphonuclear leukocyte number and function. Am J Perinatol 1992;9:285-8
43. Usmani SS, Kamran S, Harper RG, et al. Effect of maternal labor and mode of delivery on polymorphonuclear leukocyte function in healthy neonates. Pediatr Res 1993;33: 466-8
44. Buonocore G, Gioia D, De Filippo M, et al. Superoxide anion release by polymorphonuclear leukocytes in whole blood of newborns and mothers during the peripartal period. Pediatr Res 1994;36:619-22
45. Weinschenk NP, Farina A, Bianchi DW. Neonatal neutrophil activation is a function of labor length in preterm infants. Pediatr Res 1998;44:942-5
46. Jokic M, Guillois B, Cauquelin B, et al. Fetal distress increases interleukin-6 and interleukin-8 and decreases tumour necrosis factor-alpha cord blood levels in non-infected full-term neonates. Br J Obstet Gynaecol 2000;107:420-5
47. Buonocore G, De Filippo M, Gioia D, et al. Maternal and neonatal plasma cytokine levels in relation to mode of delivery. Biol Neonate 1995;68:104-10
48. Hata T, Kawamura T, Inada K, et al. Interleukin-6, interleukin-8, and granulocyte elastase in newborns with fetal distress. Gynecol Obstet Invest 1996;42:174-7
49. Schedlowski M, Jacobs R, Stratmann G, et al. Changes of natural killer cells during acute psychological stress. J Clin Immunol 1993;13:119-26
50. Dhabhar FS, Miller AH, McEwen BS, et al. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol 1995;154:5511-27
51. Dopp JM, Miller GE, Myers HF, et al. Increased natural killer-cell mobilization and cytotoxicity during marital conflict. Brain Behav Immun 2000;14:10-26
52. Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 1996;10:77-91
53. Schedlowski M, Falk A, Rohne A, et al. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol 1993;13:344-51
54. Dhabhar FS, Miller AH, McEwen BS, et al. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 1996;157:1638-44
55. Maisel AS, Harris T, Rearden CA, et al. Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 1990;82:2003-10
56. Jetschmann JU, Benschop RJ, Jacobs R, et al. Expression and in-vivo modulation of alpha-and beta-adrenoceptors on human natural killer (CD16+) cells. J Neuroimmunol 1997; 74:159-64
57. Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000;91:22-8
58. Nelson JL. Microchimerism and human autoimmune diseases. Lupus 2002;11:651-4
59. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62
60. Johnson KL, Nelson JL, Furst DE, et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthiritis Rheum 2001;44:1848-54
61. Aractingi S, Berkane N, Bertheau P, et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 1998;352: 1898-901
62. Srivatsa B, Srivatsa S, Johnson KL, et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001;358:2034-8
63. Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed fetomaternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669-72
64. Al Mufti R, Hambley H, Albaiges G, et al. Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum Reprod 2000;15:1624-8
65. Jansen MW, Korver-Hakkennes K, van Leenen D, et al. Significantly higher number of fetal cells in the maternal circulation of women with pre-eclampsia. Prenat Diagn 2001:21:1022-6
66. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8
67. Lo YM, Lo ES, Watson N, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996;88:4390-5
68. Brune T, Koch HG, Plumpe U, et al. Effect of pathological perinatal conditions on the maternofetal transfer of mononuclear cells. Fetal Diagn Ther 2002;17:110-14
69. Socie G, Gluckman E, Carosella E, et al. Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 1994;83:340-4
70. Petit T, Gluckman E, Carosella E, et al. A highly sensitive polymerase chain reaction method reveals the ubiquitous presence of maternal cells in human umbilical cord blood. Exp Hematol 1995;23:1601-5
71. Hall JM, Lingenfelter P, Adams SL, et al. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995;86:2829-32
72. Petit T, Dommergues M, Socie G, et al. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 1997;98:767-71
73. Srivatsa B, Srivatsa S, Johnson KL, et al. Maternal cell microchimerism in newborn tissues. J Pediatr 2003;142:31-5
74. Wan W, Shimizu S, Ikawa H, et al. Maternal cell traffic bounds for immune modulation: tracking maternal H-2 alleles in spleens of baby mice by DNA fingerprinting. Immunology 2002;107:261-7